{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:15:56Z","timestamp":1791141356067,"version":"4.1.0"},"reference-count":25,"publisher":"American Diabetes Association","issue":"3","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":3849,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Neonatal diabetes mellitus is a rare form of diabetes diagnosed in infancy. Nearly half of patients with permanent neonatal diabetes have mutations in the genes for the ATP-sensitive potassium channel (KCNJ11 and ABCC8) that allow switching from insulin to sulfonylurea therapy. Although treatment conversion has dramatic benefits, the cost-effectiveness of routine genetic testing is unknown.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We conducted a societal cost-utility analysis comparing a policy of routine genetic testing to no testing among children with permanent neonatal diabetes. We used a simulation model of type 1 diabetic complications, with the outcome of interest being the incremental cost-effectiveness ratio (ICER, $\/quality-adjusted life-year [QALY] gained) over 30 years of follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>In the base case, the testing policy dominated the no-testing policy. The testing policy was projected to bring about quality-of-life benefits that enlarged over time (0.32 QALYs at 10 years, 0.70 at 30 years) and produced savings in total costs that were present as early as 10 years ($12,528 at 10 years, $30,437 at 30 years). Sensitivity analyses indicated that the testing policy would remain cost-saving as long as the prevalence of the genetic defects remained &amp;gt;3% and would retain an ICER &amp;lt;$200,000\/QALY at prevalences between 0.7 and 3%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Genetic testing in neonatal diabetes improves quality of life and lowers costs. This paradigmatic case study highlights the potential economic impact of applying the concepts of personalized genetic medicine to other disorders in the future.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc10-1616","type":"journal-article","created":{"date-parts":[[2011,1,28]],"date-time":"2011-01-28T04:26:17Z","timestamp":1296188777000},"page":"622-627","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":76,"title":["The Cost-Effectiveness of Personalized Genetic Medicine"],"prefix":"10.2337","volume":"34","author":[{"given":"Siri Atma W.","family":"Greeley","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya M.","family":"John","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron N.","family":"Winn","sequence":"additional","affiliation":[{"name":"ideas42, Institute for Quantitative Social Science, Harvard University, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Ornelas","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca B.","family":"Lipton","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis H.","family":"Philipson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Section of Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois"},{"name":"Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme I.","family":"Bell","sequence":"additional","affiliation":[{"name":"Adult and Pediatric Endocrinology, Diabetes and Metabolism, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbert S.","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of General Internal Medicine, University of Chicago, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"2022031302452984500_B1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tem.2010.03.004","article-title":"Neonatal diabetes mellitus: a model for personalized medicine","volume":"21","author":"Greeley","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"2022031302452984500_B2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1464-5491.2010.02965.x","article-title":"Entities and frequency of neonatal diabetes: data from the diabetes documentation and quality management system (DPV)","volume":"27","author":"Grulich-Henn","year":"2010","journal-title":"Diabet Med"},{"key":"2022031302452984500_B3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031302452984500_B4","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031302452984500_B5","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"St\u00f8y","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022031302452984500_B6","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/db07-1405","article-title":"Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood","volume":"57","author":"Edghill","year":"2008","journal-title":"Diabetes"},{"key":"2022031302452984500_B7","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031302452984500_B8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and treatment of neonatal diabetes: a United States experience","volume":"9","author":"St\u00f8y","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"2022031302452984500_B9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-5448.2009.00548.x","article-title":"Medical and developmental impact of transition from subcutaneous insulin to oral glyburide in a 15-yr-old boy with neonatal diabetes mellitus and intermediate DEND syndrome: extending the age of KCNJ11 mutation testing in neonatal DM","volume":"11","author":"Mohamadi","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"2022031302452984500_B10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1056\/NEJMe068142","article-title":"ATP-sensitive potassium channels\u2014neonatal diabetes mellitus and beyond","volume":"355","author":"Sperling","year":"2006","journal-title":"N Engl J Med"},{"key":"2022031302452984500_B11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-150-2-200901200-00005","article-title":"Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation","volume":"150","author":"Eckman","year":"2009","journal-title":"Ann Intern Med"},{"key":"2022031302452984500_B12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc07-1785","article-title":"Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations","volume":"31","author":"Rafiq","year":"2008","journal-title":"Diabetes Care"},{"key":"2022031302452984500_B13","first-page":"80","article-title":"Expression of an activating mutation in the gene encoding the KATP channel subunit Kir6.2 in mouse pancreatic beta cells recapitulates neonatal diabetes","volume":"119","author":"Girard","year":"2009","journal-title":"J Clin Invest"},{"key":"2022031302452984500_B14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1001\/jama.1996.03540170053032","article-title":"Lifetime benefits and costs of intensive therapy as practiced in the diabetes control and complications trial","volume":"276","author":"The Diabetes Control and Complications Trial Research Group","year":"1996","journal-title":"JAMA"},{"key":"2022031302452984500_B15","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1001\/jama.287.19.2542","article-title":"Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes","volume":"287","author":"CDC Diabetes Cost-effectiveness Group","year":"2002","journal-title":"JAMA"},{"key":"2022031302452984500_B16","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1136\/bmj.320.7246.1373","article-title":"Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)","volume":"320","author":"Gray","year":"2000","journal-title":"BMJ"},{"key":"2022031302452984500_B17","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.2337\/diacare.25.12.2238","article-title":"Valuing health-related quality of life in diabetes","volume":"25","author":"Coffey","year":"2002","journal-title":"Diabetes Care"},{"key":"2022031302452984500_B18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MLR.0b013e318158af40","article-title":"Variation in treatment preferences and care goals among older patients with diabetes and their physicians","volume":"46","author":"Chin","year":"2008","journal-title":"Med Care"},{"key":"2022031302452984500_B19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.1996.03540150055031","article-title":"Recommendations of the Panel on Cost-effectiveness in Health and Medicine","volume":"276","author":"Weinstein","year":"1996","journal-title":"JAMA"},{"key":"2022031302452984500_B20","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/j.1475-6773.2007.00734.x","article-title":"The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers","volume":"42","author":"Huang","year":"2007","journal-title":"Health Serv Res"},{"key":"2022031302452984500_B21","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.2337\/dc08-1813","article-title":"Long-standing sulfonylurea therapy after pubertal relapse of neonatal diabetes in a case of uniparental paternal isodisomy of chromosome 6","volume":"32","author":"Schimmel","year":"2009","journal-title":"Diabetes Care"},{"key":"2022031302452984500_B22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1056\/NEJMra002168","article-title":"Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young","volume":"345","author":"Fajans","year":"2001","journal-title":"N Engl J Med"},{"key":"2022031302452984500_B23","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1464-5491.2009.02690.x","article-title":"A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients","volume":"26","author":"Shepherd","year":"2009","journal-title":"Diabet Med"},{"key":"2022031302452984500_B24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1464-5491.2008.02459.x","article-title":"Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)","volume":"25","author":"Eide","year":"2008","journal-title":"Diabet Med"},{"key":"2022031302452984500_B25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nrg2606","article-title":"Challenges of translating genetic tests into clinical and public health practice","volume":"10","author":"Rogowski","year":"2009","journal-title":"Nat Rev Genet"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/3\/622\/610751\/622.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/34\/3\/622\/610751\/622.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T07:02:54Z","timestamp":1647154974000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/34\/3\/622\/38742\/The-Cost-Effectiveness-of-Personalized-Genetic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,17]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,2,17]]},"published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc10-1616","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,17]]}}}